France· FR:68859538
RISEDRONATE ALTER 35 mg, comprimé pelliculé
A medicinal product containing risédronate monosodique hémipentahydraté, registered in France by LABORATOIRES ALTER, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RISÉDRONATE MONOSODIQUE HÉMIPENTAHYDRATÉ
- Manufacturer
- LABORATOIRES ALTER
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400921940206plaquette(s) PVC-Aluminium de 4 comprimé(s)EUR 9.22
- cip133400921940435plaquette(s) PVC-Aluminium de 12 comprimé(s)EUR 27.32
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Risédronate monosodique hémipentahydraté in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainACREL SEMANAL 35 mg COMPRIMIDOS RECUBIERTOS CON PELICULATheramex Ireland Limited
- ItalyACTONELFARMED S.R.L.
- BelgiumActonel 35 mg HebdomadaireImpexeco
- NetherlandsNatriumrisedronaat Sandoz Wekelijks 35 mg, filmomhulde tablettenSandoz B.V.
- FinlandRisedronat PfizerPfizer Oy
- SwedenRisedronat Ebb 35 mg Filmdragerad tablettEbb Medical AB
- PolandRisendros 35Zentiva, k.s.
- IcelandRisedronate BluefishBluefish Pharmaceuticals AB
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Germany · Risedronat Al
- Italy · Risedronato Eg Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7faaedd6-4669-4e86-ae31-9c389feec854 GET /v1/drugs/7faaedd6-4669-4e86-ae31-9c389feec854?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68859538",
"date_amm": "2011-11-24",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "RISÉDRONATE MONOSODIQUE HÉMIPENTAHYDRATÉ",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about risédronate monosodique hémipentahydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.